Feedback / Questions
fulranumab (AMG-403) - Amgen
JNJ: Pipeline Update
(J&J)
-
Jul 17, 2015 -
Anticipated BLA submission for osteoarthritis pain in 2015-2019; Anticipated EU regulatory filing for osteoarthritis pain in 2015-2019
Anticipated BLA • Anticipated EU regulatory
•
Pain
http://files.shareholder.com/downloads/JNJ/443460302x0x674691/1423ebb6-9534-413e-9af6-c0b1c429da15/JNJ_Pipeline.pdf
Jul 17, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.